Embed this press release by copying the code below:
NASDAQ:BMRN Long-Term Investor Notice: Investigation of Potential Wrongdoing at BioMarin Pharmaceutical Inc.
NASDAQ:BMRN Long-Term Investor Notice: Investigation of Potential Wrongdoing at BioMarin Pharmaceutical Inc.